M3 L5a: Antithrombotic agents Flashcards
1
Q
hemostasis
A
process that retains blood within the vascular sys
2
Q
thrombosis
A
formation of a thrombus (blood clot) within a blood vessel
3
Q
steps of hemostasis
A
injury of blood vessel -> loss of vascular integrity ->
series of 4 events:
1. vasoconstriction
2. platelet activation
3. blood coagulation and clot formation
4. fibrinolysis
4
Q
vasoconstriction
A
decreased blood flow to injured vessel -> decreased blood loss
5
Q
what is platelet activation
A
- platelets adhere to collagen fibrils on the injured vessel with the help of vWF
- platelets aggregate to each other under the effect of thrombin and fibrinogen -> platelet plug
- once activated, platelets release chemical mediators as adenosine diphosphate (ADP) and thromboxane A2 (TxA2) to activate more platelets
6
Q
blood coagulation and clot formation
A
- activation of coagulation factors -> coagulation pathway
- platelet plug turns into more stable blood clot (fibrin network + blood cells)
7
Q
fibrinolysis
A
- enzymatic process that dissolve the fibrin clot
- occurs concomitantly w coagulation
- controls the size and spread of the fibrin clot
- carried out by the enzyme plasmin
8
Q
natural anticoagulants
A
- antithrombin (AT)
nature: serine protease inhibitor
activated by: heparin
inactivates: factors 2a and 10a - protein C
nature: vitamin K- dependant protein
activated by: thrombin
inactivates: factors 5a and 8a
9
Q
abnormal hemostasis
A
- bleeding disorders
- thromboembolic disease
10
Q
3 bleeding disorders
A
- vascular defects (ex: vasculitis)
- platelet defects (ex: thrombocytopenia)
- coagulation factors defects (ex: hemophilias)
1&2 are purpura
11
Q
hemophilias
A
- bleeding disorder
- congenital or acquired (emphasis on congenital)
- due to coagulation factors deficiency: hemophilia A and factor deficiency V111 (main) but also B 1X, C X1
- bleeding: after trauma or spontaneously
12
Q
thromboembolic disease
A
- group of diseases due to hypercoagulable states
ex: deep vein thrombosis (DVT), pulmonary embolism (PE), CAD - treated by antithrombotic agents